Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No textual changes were detected; the page's Expanded Access details for Upadacitinib remain unchanged.
    Difference
    0.3%
    Check dated 2026-09-07T20:44:51.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision has been bumped from v3.6.5 to v3.6.6, indicating a newer version of the page has been published.
    Difference
    0.3%
    Check dated 2026-08-31T17:22:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Expanded Access page now lists additional eligible conditions for Upadacitinib (e.g., Hidradenitis Suppurativa, Vitiligo, Alopecia Areata, Systemic Lupus Erythematosus, Giant Cell Arteritis, Spondyloarthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Rheumatoid Arthritis) and updates related MeSH terms. Older date entries (2026-01-30, 2026-01-29, 2025-04) were removed.
    Difference
    5%
    Check dated 2026-08-24T15:57:42.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update to the UI/backend. No study details or user actions are altered by this change.
    Difference
    0.1%
    Check dated 2026-08-10T01:42:10.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.4 label, replacing the previous v3.6.3. This reflects a minor behind-the-scenes update to the site version rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-26T14:32:27.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces the prior Revision: v3.6.2, reflecting a new site revision. This is a minor update to the page's revision metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-05T04:41:19.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.